Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1

Free Radical Biology and Medicine

Volumn 33, Issue 4, 2002, Pages 562-571

  Castegna, Alessandra ^a   Aksenov, Michael ^b   Aksenova, Marina ^a   Thongboonkerd, Visith ^c   Klein, Jon B ^c   Pierce, William M ^d   Booze, Rosemarie ^b   Markesbery, William R ^b   Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Free radicals; Mass spectrometry; Oxidative stress; Protein oxidation; Proteomics

Indexed keywords

BRAIN PROTEIN; CARBONYL DERIVATIVE; CREATINE KINASE BB; GLUTAMATE AMMONIA LIGASE; HYDROLASE; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; AMYLOID PRECURSOR PROTEIN; ANAZOLENE SODIUM; CREATINE KINASE; FREE RADICAL; FUCHSINE; GLUTAMIC ACID; GLUTAMINE; ISOENZYME; MONOCLONAL ANTIBODY; NERVE PROTEIN; THIOL ESTER HYDROLASE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FINGERPRINTING; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; MALE; MASS SPECTROMETRY; NERVE DEGENERATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEOMICS; BRAIN LEVEL; CHEMISTRY; IMAGE PROCESSING; IMMUNOLOGY; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; STAINING; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; BRAIN CHEMISTRY; CREATINE KINASE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FREE RADICALS; GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; GLUTAMINE; HUMAN; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOENZYMES; NERVE DEGENERATION; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; PROTEOMICS; ROSANILINE DYES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STAINING AND LABELING; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; THIOLESTER HYDROLASES; CREATINE KINASE, BB FORM; HUMANS; UBIQUITIN THIOLESTERASE;

EID: 0037101889     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)00914-0     Document Type: Article

References (47)

1. Oxidative stress hypothesis in Alzheimer's disease
2. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress
3. Reactive oxygen-mediated protein oxidation in aging and disease
4. Protein oxidation processes in aging brain
5. Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide
6. Protein oxidation in aging brain
7. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation
8. Biochemistry and pathology of radical-mediated protein oxidation
9. Metal ion-catalyzed oxidation of proteins: Biochemical mechanism and biological consequences
10. Protein oxidation in aging, disease, and oxidative stress
11. Degradation of oxidized proteins by the 20S proteosome
12. Redox regulation of cellular signalling
13. Protein oxidation in the brain in Alzheimer's disease
14. Oxidative modification of creatine kinase BB in Alzheimer's disease brain
15. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS ADRDA work group under the auspices of Department of Health and Human Service Task Force on Alzheiemer's disease
16. Consensus recommendation for the post mortem diagnosis of Alzheimer's disease
17. Carbonyl assays for determination of oxidatively modified proteins
18. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation
19. 3-Nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: Insights into Huntington's disease
20. Oxidative modification of glutamine synthetase. II. Characterization of the ascorbate model system
21. Metal-catalyzed oxidation of Escherichia coli glutamine synthetase: Correlation of structural and functional changes
22. Oxidative modification of Escherichia coli glutamine synthetase. Decreases in the thermodynamic stability of protein structure and specific changes in the active site conformation
23. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: Relevance to Alzheimer's disease
24. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone
25. Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type
26. CSF excitatory amino acids and severity of illness in Alzheimer's disease
27. Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease
28. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: The role of Aβ1-42
29. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease
30. Oxidative modification of glutamine synthetase by amyloid beta peptide
31. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer's disease
32. The ubiquitin system
33. Modes of regulation of ubiquitin-mediated protein degradation
34. Immunohistochemical localization of ubiquitin cross-reactive protein in human tissues
35. Impaired proteasome function in Alzheimer's disease
36. Defective ubiquitination of cerebral proteins in Alzheimer's disease
37. The ubiquitin pathway in Parkinson's disease
38. Association between a polymorphism of ubiquitin carboxy-terminal hydrolase L-1 (UCH L-1) gene and sporadic Parkinson's disease
39. Loss of Uch L-1 and Uch L-3 leads to neurodegeneration posterior paralysis and dysphagia
40. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice
41. Protein oxidation and 20S proteasome-dependent proteolysis in mammalian cells
42. Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells
43. Comparative resistance of the 20S and 26S proteasome to oxidative stress
44. The lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons
45. The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons
46. Oxidative stress interference with the nuclear factor-kappa B activation pathways
47. Lipid oxidation products in cell signaling